Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The APA Just Pulled Outcomes Measurement Inside the Diagnosis
Short answer: On January 28, 2026, the American Psychiatric Association released a roadmap that proposes pulling functioning, quality of life, contextual factors, and biomarkers inside the diagnostic frame itself. For behavioral health operators running multi-site models in Florida, Texas, and Arizona, that shift changes documentation workflows, utilization management, and payer contracting inside the next 18 months.
The APA published a series of five papers from its Future DSM Strategic Committee in the American Journal of Psychiatry. The committee is a 17-member working group chaired by Dr. Maria Oquendo, chair of psychiatry at the University of Pennsylvania Perelman School of Medicine, and the papers also suggest changing the name from Diagnostic and Statistical Manual to Diagnostic and Scientific Manual to better reflect its scientific and global scope. There has been no decision yet on whether the new manual would become a DSM-6 or even a new DSM-1 because of the new title.
Committee vice-chair Jonathan Alpert, MD, PhD, told Medscape, “What we wanted to do was underscore that DSM is grounded in science first and foremost.”
The DSM is not just a clinical reference. It sits underneath diagnosis, reimbursement, utilization management, quality reporting, and population health analytics. When the APA rewrites the architecture, SAMHSA, CMS, state Medicaid agencies, and commercial payers rewrite the downstream reporting they depend on.
From Symptom Checklists to Functional Outcomes
Four subcommittees report into the Future DSM Strategic Committee, focused on social determinants of health, quality of life and functioning, biomarkers, and structure. That is a real departure from symptom thresholds and duration criteria as the primary diagnostic anchor.
Payers are already moving the same direction. CMS reports that as of January 2025, 53.4% of people with Traditional (fee-for-service) Medicare are in an accountable care relationship with a provider, representing more than 14.8 million people and marking a 4.3 percentage point increase from January 2024, the largest annual increase since CMS began tracking accountable care relationships. The stated destination is 100% of people with Traditional Medicare in an accountable care relationship by 2030.
Operators who treat PHQ-9 and GAD-7 as a clinical nicety are about to learn they were always a billing asset. As of January 2026, the Medicare national average reimbursement for CPT 96127 sits at roughly $4.97 per unit, with a maximum of 3 units per date of service. Small numbers. Run that across a Level 2.5 partial hospitalization census (an outpatient level of care) of 40 patients with twice-weekly assessments, and both the revenue line and the audit exposure compound quickly.
The harder problem is adoption. NCQA reports that key professional organizations and federal agencies (the American Psychiatric Association, SAMHSA, CMS) support measurement-based care, but studies show that fewer than 20% of behavioral health clinicians implement it, even though clinicians believe it enhances clinical decision making, strengthens therapeutic relationships and increases focus and efficiency of encounters. A peer-reviewed review in Harvard Review of Psychiatry put a finer point on it: less than 20% of practitioners (17.9% of psychiatrists, 11.1% of psychologists, and 13.9% of masters-level practitioners) engage in MBC, and as little as 5% use it according to its empirically informed schedule (every session).
AHS teams see this gap in nearly every operational assessment we run. Tools exist in the EMR. Clinical leaders have not built the workflows that make scores reliable, time-stamped, and tied to level-of-care decisions under the ASAM Criteria, 4th Edition.
Contextual Determinants and Where Audits Will Land Next
Another pillar of the roadmap is the formal integration of socioeconomic, cultural, and environmental determinants of mental health. The APA’s dedicated subcommittee was created to determine how those factors get measured and documented in clinical assessment, and how they should shape diagnosis across diverse contexts.
The volume problem is real. Among adults aged 18 or older in 2023, 22.8% (or 58.7 million people) had any mental illness in the past year, per SAMHSA’s 2023 NSDUH. And among the 48.5 million people aged 12 or older who had a SUD in 2023 and were therefore classified as needing substance use treatment, 15.6 percent (7.1 million people) received treatment and 85.4 percent (41.1 million people) did not receive substance use treatment.
Executive teams serving high-acuity, under-resourced populations cannot be benchmarked against operators serving low-acuity commercial census without contextual adjustment. The current DSM does not force that adjustment. The proposed framework does.
Executive teams in Florida, Tennessee, and Ohio should build data governance now. When clinicians capture social determinants as unstructured narrative in progress notes, those data points are not auditable, not reportable to a payer’s SIU on request, and not usable for risk adjustment.
Biomarkers, a Living Document, and Version Control You Do Not Yet Have
The roadmap also opens the door to biological markers and dimensional constructs. Medscape reported that the papers published in The American Journal of Psychiatry describe plans to make the DSM a “truly living document” that is more responsive to new scientific developments than previous versions.
Operators should read that carefully. An annually updated diagnostic framework introduces version control problems the current model never had. Today, a treatment center’s UR team works against DSM-5-TR (published 2022). Under a living-document model, the criteria a clinician documents against in Q1 may not be the criteria a payer audits against in Q4.
CEOs face a contracting problem, a documentation training problem, and a denial-management problem all at once. For organizations participating in risk-based contracts, executive teams must keep measurement systems stable enough to support longitudinal analysis. CEOs and clinical directors will need to decide which new data streams add operational value versus which add noise, cost, and compliance risk.
What CEOs Should Do in the Next 18 Months
This is not an academic exercise. Diagnosis and outcomes measurement begin to converge inside the same architecture. Behavioral health operators should be doing four things now:
- Audit the EMR. Confirm it can capture functional and quality-of-life data as structured fields, not narrative.
- Align documentation training. Tie it to both the ASAM Criteria, 4th Edition for level-of-care decisions and DSM-5-TR for diagnosis, while watching the APA’s continuous-update channel.
- Treat social determinants data as a regulated data category. Governance, retention, and access controls, not a clinical curiosity.
- Model measurement-based care unit economics at each level of care operators run, from Level 1 outpatient through Level 2.1 intensive outpatient, Level 2.5 partial hospitalization, residential levels, and residential withdrawal management.
Consider the arithmetic on a single 40-bed Level 2.5 partial hospitalization program. Twice-weekly PHQ-9/GAD-7 administration billed under CPT 96127 at roughly $4.97 per unit produces about $400 per week in ancillary revenue and roughly $20,000 per year at that one site, before commercial-payer rate variance. Now add a second site. Now add a third.
CEOs who treat DSM modernization as a documentation problem will watch UR denials climb in 2027 and 2028. CEOs who treat it as operational redesign will own a defensible payer position when commercial contracts and CMS models start pricing outcomes directly. AHS teams work with executive teams on that redesign, and we would rather have the conversation eighteen months early than eighteen months late.
Frequently asked questions
When will the next DSM be released, and what should behavioral health operators do in the meantime?
The APA has not announced a publication date. On January 28, 2026, the Future DSM Strategic Committee published its roadmap in the American Journal of Psychiatry and proposed a continuous-update ‘living document’ model, with updates likely on an annual basis rather than a single dated edition. The APA has not yet decided whether the next version will be DSM-6 or a new DSM-1. DSM-5-TR (published 2022) remains the working manual. Operators should keep documentation aligned to DSM-5-TR today while building the governance and structured-field capture needed to absorb continuous updates.
How does DSM modernization affect payer audits and utilization management?
Functional status, quality of life, and contextual factors are being proposed as part of the diagnostic structure itself, not as external overlays. UM reviewers and SIU auditors will increasingly expect those data points to be structured and time-stamped in the chart. CMS reports that 53.4% of Traditional Medicare beneficiaries were in an accountable care relationship as of January 2025 (more than 14.8 million people), on the way to a 2030 goal of 100%, and commercial payers are tracking the same direction on measurement-based care.
How wide is the gap between what payers expect and what providers actually do on measurement-based care?
Wide. NCQA cites studies showing fewer than 20% of behavioral health clinicians implement measurement-based care, despite endorsement by the American Psychiatric Association, SAMHSA, and CMS. A peer-reviewed review in Harvard Review of Psychiatry found only 17.9% of psychiatrists, 11.1% of psychologists, and 13.9% of masters-level practitioners engage in MBC, with as few as 5% using it every session. That gap is a documentation risk under current DSM-5-TR contracts and becomes a contracting risk under the future DSM model.
Does this affect ASAM level-of-care decisions for SUD treatment?
Indirectly, yes. DSM provides the diagnostic substrate; the ASAM Criteria, 4th Edition govern level-of-care placement across Level 1 outpatient, Level 2.1 intensive outpatient, Level 2.5 partial hospitalization (an outpatient level), residential levels, and residential withdrawal management. As DSM begins to incorporate functioning and contextual factors directly into diagnosis, the data feeding ASAM dimensional assessments will need to be cleaner, structured, and consistent across episodes of care.
References
- American Psychiatric Association: APA Releases Roadmap for the Future of the DSM (January 28, 2026)
- Oquendo MA et al., “Initial Strategy for the Future of DSM,” American Journal of Psychiatry (2026)
- Medscape: What Will the Next DSM Look Like?
- CMS: Moves Closer to Accountable Care Goals with 2025 ACO Initiatives
- CMS: Medicare Shared Savings Program. 100% Accountable Care by 2030 Goal
- NCQA: Measurement-Based Care in Behavioral Health. Let’s Keep Moving Forward
- Fortney JC et al., “Implementing Measurement-Based Care in Behavioral Health: A Review,” Harvard Review of Psychiatry (PMC)
- SAMHSA: 2023 National Survey on Drug Use and Health (NSDUH) Annual National Report